Pooling Clinical Data: Key points and Pitfalls. October 16, 2012 Phuse 2012 conference, Budapest Florence Buchheit

Similar documents
Pooling Clinical Data: Key points and Pitfalls

Pooling strategy of clinical data

ABSTRACT INTRODUCTION WHERE TO START? 1. DATA CHECK FOR CONSISTENCIES

How to write ADaM specifications like a ninja.

Standard Safety Visualization Set-up Using Spotfire

Introduction to ADaM and What s new in ADaM

Design of Case Report Forms. Case Report Form. Purpose. ..CRF Official clinical data-recording document or tool used in a clinical study

Guidance for the format and content of the final study report of non-interventional post-authorisation safety studies

Study Data Reviewer s Guide

Working with Composite Endpoints: Constructing Analysis Data Pushpa Saranadasa, Merck & Co., Inc., Upper Gwynedd, PA

Implementation of Data Cut Off in Analysis of Clinical Trials

Study Data Reviewer s Guide Completion Guideline

How to review a CRF - A statistical programmer perspective

Advanced Data Visualization using TIBCO Spotfire and SAS using SDTM. Ajay Gupta, PPD

Medicus TYVASO Information Architecture & Site Map v.1.4 May 14, 2009

Serious Adverse Events Reporting Form Completion Guidelines

Preparing the Office of Scientific Investigations (OSI) Requests for Submissions to FDA

Statistics and Data Analysis. Common Pitfalls in SAS Statistical Analysis Macros in a Mass Production Environment

Using PROC SQL to Generate Shift Tables More Efficiently

No conflict of interest to disclose

Customer oriented CDISC implementation

From ODM to SDTM: An End-to-End Approach Applied to Phase I Clinical Trials

A Macro for Generating the Adverse Events Summary for ClinicalTrials.gov

CPRD Aurum Frequently asked questions (FAQs)

PharmaSUG Paper DS06 Designing and Tuning ADaM Datasets. Songhui ZHU, K&L Consulting Services, Fort Washington, PA

Integrated Clinical Systems, Inc. announces JReview 13.1 with new AE Incidence

Common Programming Errors in CDISC Data

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania Kim Minkalis, Accenture Life Sciences, Wayne, Pennsylvania

Data Edit-checks Integration using ODS Tagset Niraj J. Pandya, Element Technologies Inc., NJ Vinodh Paida, Impressive Systems Inc.

Module I: Clinical Trials a Practical Guide to Design, Analysis, and Reporting 1. Fundamentals of Trial Design

Main challenges for a SAS programmer stepping in SAS developer s shoes

Solving Legacy EMR Data Access with Interoperability. Presenter: Tom Wilson Sentara Healthcare

JMP Clinical. Release Notes. Version 5.0

Monitoring of Scientific Literature

An Introduction to Analysis (and Repository) Databases (ARDs)

Bay Area CDISC Network: PhUSE Working Group for Inspection Site Selection Data Standards

Programming checks: Reviewing the overall quality of the deliverables without parallel programming

JMP Clinical. Getting Started with. JMP Clinical. Version 3.1

DIA 11234: CDER Data Standards Common Issues Document webinar questions

CDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting

Equivalence of dose-response curves

Dealing with changing versions of SDTM and Controlled Terminology (CT)

Traceability Look for the source of your analysis results

Topics Raised by EFPIA. Webinar on Policy Jun 2017, FINAL. Presentation

Standardising The Standards The Benefits of Consistency

Tips on Creating a Strategy for a CDISC Submission Rajkumar Sharma, Nektar Therapeutics, San Francisco, CA

Recent Developments in FDA s Review of Proprietary Names for Drugs

A Practical and Efficient Approach in Generating AE (Adverse Events) Tables within a Clinical Study Environment

Real Time Clinical Trial Oversight with SAS

OnCore Enterprise Research. Subject Administration Full Study

CFB: A Programming Pattern for Creating Change from Baseline Datasets Lei Zhang, Celgene Corporation, Summit, NJ

CTEP, NCI AE Reporting Guidelines and AdEERS

DCDISC Users Group. Nate Freimark Omnicare Clinical Research Presented on

Short introduction. for the. the NIC-PD study. - productive and training database -

Integrated Safety Reporting Anemone Thalmann elba - GEIGY Ltd (PH3.25), Basel

Creating Forest Plots Using SAS/GRAPH and the Annotate Facility

Automate Clinical Trial Data Issue Checking and Tracking

Acurian on. The Role of Technology in Patient Recruitment

CPRD Aurum Frequently asked questions (FAQs)

My Care Plus Your reference guide. MyCarePlusOnline.com

CREATING A SAFETY MESSAGE STEP-BY-STEP GUIDE

The ICT for Health Perspective

One-PROC-Away: The Essence of an Analysis Database Russell W. Helms, Ph.D. Rho, Inc.

Unit-of-Analysis Programming Vanessa Hayden, Fidelity Investments, Boston, MA

Standardizing FDA Data to Improve Success in Pediatric Drug Development

Advanced Visualization using TIBCO Spotfire and SAS

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania

Zambia Medicines Regulatory Authority APPLICATION FOR MARKETING AUTHORISATION OF A MEDICINE FOR HUMAN USE

The application of SDTM in a disease (oncology)-oriented organization

ehepqual- HCV Quality of Care Performance Measure Program

CDISC SDTM and ADaM Real World Issues

From SAP to BDS: The Nuts and Bolts Nancy Brucken, i3 Statprobe, Ann Arbor, MI Paul Slagle, United BioSource Corp., Ann Arbor, MI

DF/HCC Operations for Human Research Subject Registration Procedures

OC RDC 4.6. User Guide

The National Medical Device Information Sharing & Analysis Organization (MD-ISAO) Initiative Session 2, February 19, 2017 Moderator: Suzanne

From SDTM to displays, through ADaM & Analyses Results Metadata, a flight on board METADATA Airlines

QP Current Practices, Challenges and Mysteries. Caitriona Lenagh 16 March 2012

SAS CLINICAL SYLLABUS. DURATION: - 60 Hours

How a Metadata Repository enables dynamism and automation in SDTM-like dataset generation

A SAS and Java Application for Reporting Clinical Trial Data. Kevin Kane MSc Infoworks (Data Handling) Limited

Office of Human Research

1. Study Registration. 2. Confirm Registration

Clinical Workbench Product Manual Version 1.2

Considerations on creation of SDTM datasets for extended studies

Introduction to ADaM standards

PharmaSUG Paper AD15

Subgroup identification for dose-finding trials via modelbased recursive partitioning

PharmaSUG 2014 PO16. Category CDASH SDTM ADaM. Submission in standardized tabular form. Structure Flexible Rigid Flexible * No Yes Yes

Answer keys for Assignment 16: Principles of data collection

Smartphones in Medical ICU. DM SEMINAR Inderpaul Singh Sehgal

Guidance for building Study and CRF in OpenClinica

Clinical Data Visualization using TIBCO Spotfire and SAS

Practical Elements of Database Design

Classification and regulation of software

Leveraging Study Data Reviewer s Guide (SDRG) in Building FDA s Confidence in Sponsor s Submitted Datasets

extended EudraVigilance Medicinal Product Dictionary (XEVMPD) e-learning

Analysis of the Central District Clinic

Exam Questions A00-281

Matt Downs and Heidi Christ-Schmidt Statistics Collaborative, Inc., Washington, D.C.

Unique Technology for the Future

Transcription:

Pooling Clinical Data: Key points and Pitfalls October 16, 2012 Phuse 2012 conference, Budapest Florence Buchheit

Introduction Are there any pre-defined rules to pool clinical data? Are there any pre-defined steps to pool clinical data? What is the right way to pool clinical data? 2 Pooling Clinical Data: Key points and Pitfalls Oct 16, 2012

Agenda Purpose of the pool Planning Execution Possible pitfalls 3 Pooling Clinical Data: Key points and Pitfalls Oct 16, 2012

Purpose of the pool - showing safety profile across whole program - improving the precision of incidence estimate for main efficacy analysis - identifying rare safety signals - exploration of possible drug-demographic, drug-disease or drug-drug interactions in subgroups of populations. But The quality of the pool is dependent on the individual trials used 4 Pooling Clinical Data: Key points and Pitfalls Oct 16, 2012

Purpose of the pool It is often most appropriate to combine data from studies that are of similar design (dose, duration, control and population) 5 Pooling Clinical Data: Key points and Pitfalls Oct 16, 2012

Purpose of the pool Business reasons: 6 Pooling Clinical Data: Key points and Pitfalls Oct 16, 2012

Planning Earlier the better Consideration of health autorities, medical expert input Pooling strategy : stand-alone versus periodic update 7 Pooling Clinical Data: Key points and Pitfalls Oct 16, 2012

Planning Purpose, needs, periodic update Details of studies, populations, data to include Details of algorithms, list & shells of outputs Including mapping data, derived variables, validation plan Timelines can be split in sub-timelines Timelines can be split in sub-timelines If agreed Timelines can be split in sub-timelines 8 Pooling Clinical Data: Key points and Pitfalls Oct 16, 2012

Planning Pooling content - safety: Duration of treatment exposure Adverse events, SAEs (including deaths) and ADRs Specific defined risks of interest Lab values Further areas of potential interest : Vital signs, specifically solicited events captured outside of standard panels (e.g. immunogenicity problems), ECG... Pooling content - efficacy: Depends on the compound Focus on key endpoint Analysis of subgroup 9 Pooling Clinical Data: Key points and Pitfalls Oct 16, 2012

Execution Mapping study level data to pool level: Mapping process: comparison of - Meta data - Code lists - Endpoints - Algorithms Increase of mapping work if legacy data, outsourced studies or locally run studies Creation of reports to compare raw and analysis data and meta data for a given study with the final pooled dataset 10 Pooling Clinical Data: Key points and Pitfalls Oct 16, 2012

Execution: raw versus derived 11 Pooling Clinical Data: Key points and Pitfalls Oct 16, 2012

Execution: programs strategy 12 Pooling Clinical Data: Key points and Pitfalls Oct 16, 2012

Documentation and validation consideration Documentation: Tracking information regarding data pools centrally to provide an easy reference in cases where multiple requests come Validation: Risks assessment Validation strategy Review data is mapped as required Cross check between pooled and study level data 13 Pooling Clinical Data: Key points and Pitfalls Oct 16, 2012

Possible pitfalls Mapping of treatments: Treatments are presented differently in pooled outputs compared to study level Special care for studies with multiple periods, down-up titrations, add-on therapies STUDIES Pooled Trt var Trt description Study 1 Study 2 Study 3 Ext Study 3 Study 4 Study 5 Study 6 In derived dataset T1 Treatment A A A A B B T2 Treatment B C B B, C A A T3 Comparator C A C A T4 Comparator D C B T5 Placebo B B C D C In outputs All Trt Output type 1 Output Trt All Active Comp Placebo Pooled trt var T1, T2 T3, T4 T5 Output Trt Treatment A Treatment B All Comp Output type 2 Pooled trt var T1 T2 T3, T4, T5 14 Pooling Clinical Data: Key points and Pitfalls Oct 16, 2012

Possible pitfalls Mapping of visit window and timepoints: Are pre-dose assessments in all pooled studies consistent? Are key reporting visits consistent across trials? Extension studies: On which treatment should patients who switch treatment from core to extension be considered? Should we consider baseline as core baseline or end of core study? How to handle of duplicate records (events starting in a core study and continuing to its extension) 15 Pooling Clinical Data: Key points and Pitfalls Oct 16, 2012

Possible pitfalls Interim analysis How to determine the cut-off point for interim analysis (include all data up to a specific date? a specific visit? include only patients who completed the study? etc.) Coding Studies coded using different versions of a coding dictionary (MedDRA and WHO DRL dictionaries). Re-code using the latest version available 16 Pooling Clinical Data: Key points and Pitfalls Oct 16, 2012

Conclusion No obvious right or wrong way to pool data but they are many points that need to be well thought in advance. Early planning Clear pooling strategy Programming strategies: raw versus derived / one hit approach versus modular approach should be considered depending on the pool objectives, update, data availability Pooling will be facilitating if adherence to standards 17 Pooling Clinical Data: Key points and Pitfalls Oct 16, 2012

Questions? 18 Pooling Clinical Data: Key points and Pitfalls Oct 16, 2012